01—Abstract
Summary
Summary of the 8-K filed May 7, 2026. Cited figures are marked; the original filing is the authoritative source.
Eli Lilly and Company (LLY) held its 2026 Annual Meeting of Shareholders on May 4, 2026, with a strong turnout of approximately 90%a of outstanding shares participating in the vote.
Key outcomes include the re-election of four directors, Carolyn Bertozzi, William Kaelin, Jr., Jon Moeller, and David Ricks, to three-year terms. Additionally, shareholders provided advisory approval for the compensation of named executive officers and ratified the appointment of Ernst & Young LLP as the independent auditor for 2026, both with significant support. However, two significant proposals to amend the Company's Articles of Incorporation, one to eliminate the classified board structure and another to remove supermajority voting provisions, failed to gain the required 80%b approval from outstanding shares.
Furthermore, shareholder proposals requesting an independent board chair and an annual lobbying report were also not approved. These voting results indicate continued shareholder confidence in the current board and executive compensation practices, while also highlighting resistance to certain governance structure changes at this time.
02—Key points
Key Highlights
- Four directors (Carolyn Bertozzi, William Kaelin, Jr., Jon Moeller, David Ricks) were re-elected to serve three-year terms ending in 2029.
- Shareholders provided advisory approval for the compensation of named executive officers with substantial support.
- Ernst & Young LLP was ratified as the independent auditor for 2026.
- A proposal to eliminate the classified board structure did not receive the required 80% approval from outstanding shares.
- A proposal to eliminate supermajority voting provisions also failed to meet the required 80% approval threshold.
- Shareholder proposals for an independent board chair and an annual lobbying report were not approved.
03—Questions
Frequently Asked Questions
What were the main outcomes of the Eli Lilly 2026 Annual Meeting of Shareholders?
The main outcomes include the re-election of four directors, advisory approval of executive compensation, and ratification of the independent auditor. However, proposals to change the board structure and voting provisions did not pass, and two shareholder proposals were also rejected.
Why did the proposals to amend the Articles of Incorporation fail?
Both the proposal to eliminate the classified board and the proposal to eliminate supermajority voting provisions failed because they did not receive the required 80% of outstanding shares for approval, despite receiving a majority of votes cast.
What is the significance of the advisory vote on executive compensation?
The advisory vote, often referred to as 'Say-on-Pay', allows shareholders to express their opinion on the company's executive compensation practices. The strong approval indicates shareholder satisfaction with how the company is compensating its named executive officers.
What does it mean that Ernst & Young LLP was 'ratified' as the independent auditor?
Ratification means shareholders approved the Board of Directors' decision to appoint Ernst & Young LLP as the company's independent auditor for the fiscal year 2026. This is a common practice to ensure auditor independence and shareholder oversight.
04—Continue